HOME » Pipeline


    Vyome is an innovation driven company which develops novel, first-in-class treatment options for significant unmet needs in Dermatology.

    Vyome targets antibiotic resistant acne and other opportunistic pathogens with its unique pipeline of drugs that retard the development of antimicrobial resistance. 


    Other Products:

    Pipeline of Anti-Fungal Products
    - Molecular Replament Therapeutics 
    (MRTTM) and Treatment for Recalcitrant Fungal Infections - in clinical & commercial stages. For Pipeline and partnership opportunities, visit- Partnership Opportunities.

    For partnership queries, write to nvenkat@vyometx.com.

    Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.